Rojeet Shrestha
- Molecular Biology
- Infectious Diseases top 10%
- Endocrinology, Diabetes and Metabolism
- Epidemiology
- Biomedical Engineering
- Co-authors
- Puja NeopaneHari Prasad NepalHitoshi ChibaYoshihiro AbikoOsamu UeharaShu‐Ping HuiZhen ChenHirotoshi Fuda
- Topics
- Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers)Metabolomics and Mass Spectrometry Studies (7 papers)Liver Disease Diagnosis and Treatment (7 papers)
- Partner nations
- JapanNepalUnited States
In The Last Decade
Rojeet Shrestha
46 papers receiving 598 citations
Peers
Comparison fields: 5 of 111
- Molecular Biology 290
- Infectious Diseases 125
- Endocrinology, Diabetes and Metabolism 72
- Epidemiology 68
- Biomedical Engineering 57
Countries citing papers authored by Rojeet Shrestha
This map shows the geographic impact of Rojeet Shrestha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rojeet Shrestha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rojeet Shrestha more than expected).
Fields of papers citing papers by Rojeet Shrestha
This network shows the impact of papers produced by Rojeet Shrestha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rojeet Shrestha. The network helps show where Rojeet Shrestha may publish in the future.
Co-authorship network of co-authors of Rojeet Shrestha
This figure shows the co-authorship network connecting the top 25 collaborators of Rojeet Shrestha. A scholar is included among the top collaborators of Rojeet Shrestha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rojeet Shrestha. Rojeet Shrestha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 9 | |
| 3 | 35 | |
| 4 | 22 | |
| 5 | 28 | |
| 6 | 4 | |
| 7 | 138 | |
| 8 | 22 | |
| 9 | 6 | |
| 10 | 8 | |
| 11 | 7 | |
| 12 | 1 | |
| 13 | 11 | |
| 14 | 3 | |
| 15 | 10 | |
| 16 | 6 | |
| 17 | 4 | |
| 18 | Use of protein: creatinine ratio in a random spot urine sample for predicting significant proteinuria in diabetes mellitus. | 14 |
| 19 | 5 | |
| 20 | 13 |
About Rojeet Shrestha
Rojeet Shrestha is a scholar working on Biochemistry, Endocrinology, Diabetes and Metabolism and Biochemistry, having authored 46 papers that have together received 625 indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers), Metabolomics and Mass Spectrometry Studies (7 papers) and Liver Disease Diagnosis and Treatment (7 papers). The work is most often cited by research in Infectious Diseases (125 citations), Microbiology (37 citations) and Molecular Medicine (26 citations). Rojeet Shrestha has collaborated with scholars based in Japan, Nepal and United States. Frequent co-authors include Puja Neopane, Hari Prasad Nepal, Hitoshi Chiba, Yoshihiro Abiko, Osamu Uehara, Shu‐Ping Hui, Zhen Chen, Hirotoshi Fuda, Bibek Poudel and Seiji Takeda. Their work appears in journals such as Scientific Reports, Clinica Chimica Acta and Gynecologic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.